Table of Contents

company-logo

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic ductal adenocarcinoma. The company was formerly known as Sun BioPharma, Inc. and changed its name to Panbela Therapeutics, Inc. in December 2020. Panbela Therapeutics, Inc. was incorporated in 2011 and is based in Waconia, Minnesota.

Panbela Therapeutics Dividend Announcement

• Panbela Therapeutics does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Panbela Therapeutics dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Panbela Therapeutics Dividend History

Panbela Therapeutics Dividend Yield

Panbela Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Panbela Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Panbela Therapeutics Financial Ratios

P/E ratio-0.06
PEG ratio-0.00
P/B ratio-0.09
ROE304.71%
Payout ratio0.00%
Current ratio0.26
Quick ratio0.26
Cash Ratio0.01

Panbela Therapeutics Dividend FAQ

Does Panbela Therapeutics stock pay dividends?
Panbela Therapeutics does not currently pay dividends to its shareholders.
Has Panbela Therapeutics ever paid a dividend?
No, Panbela Therapeutics has no a history of paying dividends to its shareholders. Panbela Therapeutics is not known for its dividend payments.
Why doesn't Panbela Therapeutics pay dividends?
There are several potential reasons why Panbela Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Panbela Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Panbela Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Panbela Therapeutics a dividend aristocrat?
Panbela Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Panbela Therapeutics a dividend king?
Panbela Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Panbela Therapeutics a dividend stock?
No, Panbela Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Panbela Therapeutics stocks?
To buy Panbela Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Panbela Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.